EMRELIS Trademark

Trademark Overview


On Friday, March 19, 2021, a trademark application was filed for EMRELIS with the United States Patent and Trademark Office. The USPTO has given the EMRELIS trademark a serial number of 90589473. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 18, 2022. This trademark is owned by Allergan Sales, LLC. The EMRELIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; Oral, transdermal, injectable and intravaginal contraceptives; Intravaginal contraceptive sponge; Fertility enhancing preparations; Pharmaceutical preparations for the treatment of headaches, hyperhidrosis, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body; Human allograft tissue; Processed human do...
emrelis

General Information


Serial Number90589473
Word MarkEMRELIS
Filing DateFriday, March 19, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 18, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; Oral, transdermal, injectable and intravaginal contraceptives; Intravaginal contraceptive sponge; Fertility enhancing preparations; Pharmaceutical preparations for the treatment of headaches, hyperhidrosis, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body; Human allograft tissue; Processed human donor skin for tissue regeneration and reconstruction; human tissue for transplantation purposes; Implants consisting of non-living biological materials for use in the surgical repair and reinforcement of soft tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAllergan Sales, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressIrvine, CA 92612

Party NameAllergan Sales, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressIrvine, CA 92612

Trademark Events


Event DateEvent Description
Monday, July 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 14, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 14, 2021ASSIGNED TO EXAMINER
Tuesday, June 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 23, 2021NEW APPLICATION ENTERED IN TRAM